AI assistant
Sending…
Predictive Oncology Inc. — Director's Dealing 2023
Oct 4, 2023
35106_dirs_2023-10-04_0e894a1b-904e-48d7-9c19-a800d5e7c6f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2023-10-02
Reporting Person: Hawryluk Matthew (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-10-02 | Common Stock | A | 1875 | — | Acquired | 7135 | Direct |
More from Predictive Oncology Inc.
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 1
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9